127 related articles for article (PubMed ID: 28615929)
1. Impact of serum-derived bovine immunoglobulin/protein isolate therapy on irritable bowel syndrome and inflammatory bowel disease: a survey of patient perspective.
Shaw AL; Tomanelli A; Bradshaw TP; Petschow BW; Burnett BP
Patient Prefer Adherence; 2017; 11():1001-1007. PubMed ID: 28615929
[TBL] [Abstract][Full Text] [Related]
2. New therapeutic option for irritable bowel syndrome: serum-derived bovine immunoglobulin.
Good L; Rosario R; Panas R
World J Gastroenterol; 2015 Mar; 21(11):3361-6. PubMed ID: 25805945
[TBL] [Abstract][Full Text] [Related]
3. Serum-derived bovine immunoglobulin for children with diarrhea-predominant irritable bowel syndrome.
Arrouk R; Herdes RE; Karpinski AC; Hyman PE
Pediatric Health Med Ther; 2018; 9():129-133. PubMed ID: 30498390
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of serum-derived bovine immunoglobulin protein isolate in subjects with diarrhea-predominant irritable bowel syndrome.
Wilson D; Evans M; Weaver E; Shaw AL; Klein GL
Clin Med Insights Gastroenterol; 2013; 6():49-60. PubMed ID: 24833942
[TBL] [Abstract][Full Text] [Related]
5. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet.
Maagaard L; Ankersen DV; Végh Z; Burisch J; Jensen L; Pedersen N; Munkholm P
World J Gastroenterol; 2016 Apr; 22(15):4009-19. PubMed ID: 27099444
[TBL] [Abstract][Full Text] [Related]
6. Potential mechanisms of effects of serum-derived bovine immunoglobulin/protein isolate therapy in patients with diarrhea-predominant irritable bowel syndrome.
Valentin N; Camilleri M; Carlson P; Harrington SC; Eckert D; O'Neill J; Burton D; Chen J; Shaw AL; Acosta A
Physiol Rep; 2017 Mar; 5(5):. PubMed ID: 28275113
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in patients with inflammatory bowel disease and irritable bowel syndrome differs between subjects recruited from clinic or the internet.
Jones MP; Bratten J; Keefer L
Am J Gastroenterol; 2007 Oct; 102(10):2232-7. PubMed ID: 17680842
[TBL] [Abstract][Full Text] [Related]
8. Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome.
Tuteja AK; Talley NJ; Stoddard GJ; Verne GN
Dig Dis Sci; 2019 Mar; 64(3):838-845. PubMed ID: 30370492
[TBL] [Abstract][Full Text] [Related]
9. Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease.
Gracie DJ; Williams CJ; Sood R; Mumtaz S; Bholah MH; Hamlin PJ; Ford AC
Clin Gastroenterol Hepatol; 2017 Mar; 15(3):376-384.e5. PubMed ID: 27189912
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea.
Buono JL; Carson RT; Flores NM
Health Qual Life Outcomes; 2017 Feb; 15(1):35. PubMed ID: 28196491
[TBL] [Abstract][Full Text] [Related]
11. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome.
Halmos EP; Power VA; Shepherd SJ; Gibson PR; Muir JG
Gastroenterology; 2014 Jan; 146(1):67-75.e5. PubMed ID: 24076059
[TBL] [Abstract][Full Text] [Related]
12. Clinical Efficacy of Serum-Derived Bovine Immunoglobulin in Patients With Refractory Inflammatory Bowel Disease.
Liaquat H; Ashat M; Stocker A; McElmurray L; Beatty K; Abell TL; Dryden G
Am J Med Sci; 2018 Dec; 356(6):531-536. PubMed ID: 30342719
[TBL] [Abstract][Full Text] [Related]
13. Double-blind placebo-controlled study of mesalamine in post-infective irritable bowel syndrome--a pilot study.
Tuteja AK; Fang JC; Al-Suqi M; Stoddard GJ; Hale DC
Scand J Gastroenterol; 2012 Oct; 47(10):1159-64. PubMed ID: 22783919
[TBL] [Abstract][Full Text] [Related]
14. Management of inflammatory bowel disease with oral serum-derived bovine immunoglobulin.
Shafran I; Burgunder P; Wei D; Young HE; Klein G; Burnett BP
Therap Adv Gastroenterol; 2015 Nov; 8(6):331-9. PubMed ID: 26557889
[TBL] [Abstract][Full Text] [Related]
15. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.
Singh P; Staller K; Barshop K; Dai E; Newman J; Yoon S; Castel S; Kuo B
World J Gastroenterol; 2015 Jul; 21(26):8103-9. PubMed ID: 26185382
[TBL] [Abstract][Full Text] [Related]
16. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS
Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
[TBL] [Abstract][Full Text] [Related]
17. Irritable Bowel Syndrome Patient Experience: A Survey of Patient-Reported Symptoms by Irritable Bowel Syndrome Subtype and Impact on Quality of Life.
Bhinder G; Meza-Cardona JM; Low A; Aumais G; Attara GP; Gray JR
J Can Assoc Gastroenterol; 2023 Dec; 6(6):219-228. PubMed ID: 38106485
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.
Abdalla MI; Sandler RS; Kappelman MD; Martin CF; Chen W; Anton K; Long MD
Inflamm Bowel Dis; 2017 Feb; 23(2):325-331. PubMed ID: 28092305
[TBL] [Abstract][Full Text] [Related]
19. Further characterization of painful constipation (PC): clinical features over one year and comparison with IBS.
Drossman DA; Morris C; Hu Y; Leserman J; Dalton C; Toner B; Diamante N; Bangdiwala S
J Clin Gastroenterol; 2008; 42(10):1080-8. PubMed ID: 18949838
[TBL] [Abstract][Full Text] [Related]
20. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
